Takakuwa, Teruhito https://orcid.org/0000-0001-5259-0450
Okayama, Yusuke
Nakamae, Hirohisa
Kuno, Masatomo
Makuuchi, Yosuke
Harada, Naonori
Okamura, Hiroshi
Nishimoto, Mitsutaka
Nakashima, Yasuhiro
Koh, Hideo
Hino, Masayuki
Funding for this research was provided by:
Pfizer Japan
Chugai Pharmaceutical
SymBio Pharmaceuticals Limited
Article History
Received: 14 February 2022
Accepted: 16 February 2022
First Online: 26 February 2022
Declarations
:
: This report was exempt from ethical approval according to the World Medical Association Declaration of Helsinki.
: A written informed consent to publish was obtained from the patient.
: MN reports research funding from Pfizer. YN reports research funding from Chugai Pharm. and SymBio. HK reports research funding from Chugai Pharm. MH reports research funding from Pfizer. All other authors have no conflict of interest to declare.